questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Lectines
Galectines
Galectine -3
Galectine -3 : Questions médicales fréquentes
Termes MeSH sélectionnés :
Reproducibility of Results
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Galectine -3 : Questions médicales les plus fréquentes",
"headline": "Galectine -3 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Galectine -3 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-17",
"dateModified": "2025-02-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Galectine -3"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Galectines",
"url": "https://questionsmedicales.fr/mesh/D037161",
"about": {
"@type": "MedicalCondition",
"name": "Galectines",
"code": {
"@type": "MedicalCode",
"code": "D037161",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.503.307"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Galectine -3",
"alternateName": "Galectin 3",
"code": {
"@type": "MedicalCode",
"code": "D037502",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Çiğdem Yücel",
"url": "https://questionsmedicales.fr/author/%C3%87i%C4%9Fdem%20Y%C3%BCcel",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, University of Health Science, Ankara City Hospital, Ankara, Turkey."
}
},
{
"@type": "Person",
"name": "Aybeniz Civan Kahve",
"url": "https://questionsmedicales.fr/author/Aybeniz%20Civan%20Kahve",
"affiliation": {
"@type": "Organization",
"name": "Gazi University Faculty of Medicine, Department of Psychiatry, Ankara, Turkey."
}
},
{
"@type": "Person",
"name": "Işık Batuhan Çakmak",
"url": "https://questionsmedicales.fr/author/I%C5%9F%C4%B1k%20Batuhan%20%C3%87akmak",
"affiliation": {
"@type": "Organization",
"name": "Sungurlu State Hospital, Department of Psychiatry, Corum, Turkey."
}
},
{
"@type": "Person",
"name": "Erol Göka",
"url": "https://questionsmedicales.fr/author/Erol%20G%C3%B6ka",
"affiliation": {
"@type": "Organization",
"name": "University of Health Sciences, Ankara City Hospital, Department of Psychiatry, Ankara, Turkey."
}
},
{
"@type": "Person",
"name": "Massiullah Shafaq-Zadah",
"url": "https://questionsmedicales.fr/author/Massiullah%20Shafaq-Zadah",
"affiliation": {
"@type": "Organization",
"name": "Institut Curie, PSL Research University, U1143 INSERM, UMR3666 CNRS, Cellular and Chemical Biology Unit, 75248Paris Cedex 05, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A grassroots approach to peer support by the Danish Reproducibility Network.",
"datePublished": "2024-09-10",
"url": "https://questionsmedicales.fr/article/39256756",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13104-024-06912-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Advice for improving the reproducibility of data extraction in meta-analysis.",
"datePublished": "2023-08-11",
"url": "https://questionsmedicales.fr/article/37571802",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jrsm.1663"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reproducibility of pulmonary function tests in patients with systemic sclerosis.",
"datePublished": "2023-11-03",
"url": "https://questionsmedicales.fr/article/37923803",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-45881-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reproducibility of Bartoníček and Haraguchi classifications of the posterior malleolus fractures.",
"datePublished": "2023-03-11",
"url": "https://questionsmedicales.fr/article/36905426",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00402-023-04823-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reproducibility of cerebral perfusion measurements using BOLD delay.",
"datePublished": "2023-02-25",
"url": "https://questionsmedicales.fr/article/36840928",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/hbm.26244"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Lectines",
"item": "https://questionsmedicales.fr/mesh/D037102"
},
{
"@type": "ListItem",
"position": 5,
"name": "Galectines",
"item": "https://questionsmedicales.fr/mesh/D037161"
},
{
"@type": "ListItem",
"position": 6,
"name": "Galectine -3",
"item": "https://questionsmedicales.fr/mesh/D037502"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Galectine -3 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Galectine -3",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Galectine -3",
"description": "Comment mesurer le taux de galectine-3 ?\nQuels tests sont utilisés pour le diagnostic ?\nLa galectine-3 est-elle un biomarqueur ?\nQuels médecins évaluent la galectine-3 ?\nPeut-on détecter la galectine-3 dans l'urine ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Reproducibility+of+Results&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Galectine -3",
"description": "Quels symptômes sont liés à la galectine-3 ?\nLa galectine-3 cause-t-elle des douleurs ?\nY a-t-il des symptômes cardiaques associés ?\nLa galectine-3 est-elle liée à la fatigue ?\nQuels signes cliniques sont observés ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Reproducibility+of+Results&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Galectine -3",
"description": "Comment prévenir l'augmentation de la galectine-3 ?\nL'exercice physique influence-t-il la galectine-3 ?\nY a-t-il des aliments à éviter ?\nLe stress affecte-t-il la galectine-3 ?\nDes suppléments peuvent-ils aider à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Reproducibility+of+Results&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Galectine -3",
"description": "Quels traitements ciblent la galectine-3 ?\nLa galectine-3 peut-elle être traitée par des médicaments ?\nY a-t-il des traitements naturels pour la galectine-3 ?\nLes traitements varient-ils selon la maladie ?\nLa thérapie génique peut-elle cibler la galectine-3 ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Reproducibility+of+Results&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Galectine -3",
"description": "Quelles complications sont liées à la galectine-3 ?\nLa galectine-3 aggrave-t-elle les maladies ?\nY a-t-il des risques de cancer associés ?\nLa galectine-3 influence-t-elle la fibrose ?\nDes complications neurologiques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Reproducibility+of+Results&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Galectine -3",
"description": "Quels facteurs augmentent la galectine-3 ?\nLe tabagisme influence-t-il la galectine-3 ?\nL'âge est-il un facteur de risque ?\nLe stress chronique est-il un facteur de risque ?\nY a-t-il un lien avec les maladies auto-immunes ?",
"url": "https://questionsmedicales.fr/mesh/D037502?mesh_terms=Reproducibility+of+Results&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer le taux de galectine-3 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le taux de galectine-3 se mesure par un test sanguin spécifique."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des examens d'imagerie peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "La galectine-3 est-elle un biomarqueur ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est considérée comme un biomarqueur pour certaines maladies."
}
},
{
"@type": "Question",
"name": "Quels médecins évaluent la galectine-3 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cardiologues et oncologues évaluent souvent la galectine-3."
}
},
{
"@type": "Question",
"name": "Peut-on détecter la galectine-3 dans l'urine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La galectine-3 est principalement mesurée dans le sang, pas dans l'urine."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à la galectine-3 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est associée à des symptômes d'inflammation et de fibrose."
}
},
{
"@type": "Question",
"name": "La galectine-3 cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut contribuer à des douleurs liées à des maladies inflammatoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cardiaques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme l'essoufflement peuvent être présents."
}
},
{
"@type": "Question",
"name": "La galectine-3 est-elle liée à la fatigue ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être associée à la fatigue dans des conditions inflammatoires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont observés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme l'œdème et la dyspnée peuvent être observés."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'augmentation de la galectine-3 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée, peut aider."
}
},
{
"@type": "Question",
"name": "L'exercice physique influence-t-il la galectine-3 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut réduire les niveaux de galectine-3."
}
},
{
"@type": "Question",
"name": "Y a-t-il des aliments à éviter ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les aliments transformés et riches en sucres peut être bénéfique."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il la galectine-3 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut augmenter les niveaux de galectine-3."
}
},
{
"@type": "Question",
"name": "Des suppléments peuvent-ils aider à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments, comme les oméga-3, peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent la galectine-3 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs de galectine-3 sont en développement pour diverses maladies."
}
},
{
"@type": "Question",
"name": "La galectine-3 peut-elle être traitée par des médicaments ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments visent à réduire son activité dans le corps."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels pour la galectine-3 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches diététiques et des suppléments peuvent aider à la réguler."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon la maladie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements dépendent de la maladie associée à la galectine-3."
}
},
{
"@type": "Question",
"name": "La thérapie génique peut-elle cibler la galectine-3 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches explorent la thérapie génique pour moduler son expression."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à la galectine-3 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est liée à des complications cardiovasculaires et pulmonaires."
}
},
{
"@type": "Question",
"name": "La galectine-3 aggrave-t-elle les maladies ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aggraver des maladies comme l'insuffisance cardiaque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de galectine-3 sont associés à un risque accru de cancer."
}
},
{
"@type": "Question",
"name": "La galectine-3 influence-t-elle la fibrose ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle joue un rôle clé dans le développement de la fibrose tissulaire."
}
},
{
"@type": "Question",
"name": "Des complications neurologiques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien entre galectine-3 et maladies neurodégénératives."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent la galectine-3 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le diabète et l'inflammation chronique augmentent la galectine-3."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il la galectine-3 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque pour des niveaux élevés."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux de galectine-3 augmentent souvent avec l'âge."
}
},
{
"@type": "Question",
"name": "Le stress chronique est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à des niveaux élevés de galectine-3."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien avec les maladies auto-immunes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies auto-immunes peuvent augmenter les niveaux de galectine-3."
}
}
]
}
]
}
The Danish Reproducibility Network (DKRN) is a grassroots initiative for establishing a peer-supportive reproducibility-focused academic network in Denmark. We modelled our approach on already existin...
Extracting data from studies is the norm in meta-analyses, enabling researchers to generate effect sizes when raw data are otherwise not available. While there has been a general push for increased re...
Systemic sclerosis (SSc) is a rare autoimmune disease in which interstitial lung disease (ILD) is the leading cause of morbidity and mortality. Clinical management of the lung disease is mainly based ...
Two of the most commonly used classifications for the posterior malleolus fracture are Haraguchi and Bartoníček. Both classifications are based on the morphology of the fracture. This study makes an i...
39 patients with ankle fractures who met inclusion criteria were selected. All the fractures were analyzed and classified twice by each of the 20 observers using Bartoníček and Haraguchi's classificat...
Analysis was made by Kappa coefficient (ƙ). The global intraobserver value was ƙ = 0.627 in the Bartoníček classification and ƙ = 0.644 in the Haraguchi one. The first round global interobserver ƙ = 0...
Bartoníček and Haraguchi classifications of the posterior malleolus fracture have both substantial intraobserver agreement but moderate to substantial agreement in interobserver analysis....
IV....
BOLD delay is an emerging, noninvasive method for assessing cerebral perfusion that does not require the use of intravenous contrast agents and is thus particularly suited for longitudinal monitoring....
This study analyzes the effects of retrospective lipid suppression, a simulated macromolecular prior knowledge and different spline baseline stiffness values on 9.4T multi-slice proton FID-MRSI data s...
Measurements were performed twice on 5 volunteers using a short TR and TE FID MRSI 2D sequence at 9.4T. The effects of retrospective lipid L2-regularization, macromolecular spectrum and different LCMo...
Transversal, sagittal, and coronal slices of many metabolite ratio maps correspond to the anatomically expected concentration relations in gray and white matter for the majority of the cerebrum when u...
Reproducible concentration ratio maps (/tCr) for 4 metabolites (total choline, N-acetylaspartate, glutamate, and myoinositol) spanning the majority of the cerebrum and 6 metabolites (N-acetylaspartylg...
Many researchers try to understand a biological condition by identifying biomarkers. This is typically done using univariate hypothesis testing over a labeled dataset, declaring a feature to be a biom...
Nanoforms (NFs) of a substance may be distinguished from one another through differences in their physicochemical properties. When registering nanoforms of a substance for assessment under the EU REAC...
Immortalized or continuous cell lines are invaluable tools in basic and preclinical research. However, the widespread use of misidentified cell lines is a serious threat to scientific reproducibility....
Videogames are emerging as a promising experimental paradigm in neuroimaging. Acquiring gameplay in a scanner remains challenging due to the lack of a scanner-compatible videogame controller that prov...